SER- Serina Therapeutics, Inc.
Over the past 90 days, insiders at Serina Therapeutics, Inc. (SER) have been net buyers, picking up 11,689 shares worth roughly $21K on balance.
SER sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 231.7K | $644.1K | - | |
| CEO | 230.1K | $639.7K | - | |
| Dir | 92.0K | $255.8K | - | |
| VP | 85.6K | $237.9K | - | |
| Dir | 30.5K | $84.8K | - |
Activity
Buys and sells only
Transactions
10 filings · page 4
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Moreadith Randall89 | Chief Scientific Officer | Sale+OE | 5,500 | $5.25 | $28,875.00 | -100% | -26.9% | - | |
| Aug 4, 2025 | Moreadith Randall89 | Chief Scientific Officer | Sale+OE | 5,500 | $5.17 | $28,435.00 | -100% | -8.8% | -60.3% | |
| Jul 29, 2025 | Moreadith Randall89 | Chief Scientific Officer | Sale+OE | 4,196 | $6.50 | $27,274.00 | -100% | -15.0% | -65.3% | |
| Jul 28, 2025 | Moreadith Randall89 | Chief Scientific Officer | Sale+OE | 6,500 | $5.89 | $38,285.00 | -100% | -11.3% | -63.8% | |
| Jul 21, 2025 | Moreadith Randall89 | Chief Scientific Officer | Sale+OE | 6,500 | $5.34 | $34,710.00 | -100% | -9.5% | -60.9% | |
| Jul 14, 2025 | Moreadith Randall89 | Chief Scientific Officer | Sale+OE | 6,500 | $5.01 | $32,565.00 | -100% | -2.7% | -59.4% | |
| Jul 7, 2025 | Moreadith Randall89 | Chief Scientific Officer | Sale+OE | 6,500 | $5.67 | $36,855.00 | -100% | -6.5% | -60.9% | |
| Jun 30, 2025 | Moreadith Randall89 | Chief Scientific Officer | Sale+OE | 6,500 | $5.78 | $37,570.00 | -100% | -20.6% | -68.5% | |
| Dec 17, 2024 | Bailey Gregory | Director | Buy | 3,866 | $4.59 | $17,744.55 | +6.1% | -8.2% | -38.6% | |
| Sep 20, 2024 | Bailey Gregory | Director | Buy | 1,137 | $6.03 | $6,851.45 | +1.8% | -16.4% | -24.0% |